Compositions and methods for regulating car t cells

作者: Carl H. June , Michael D. Kalos , Bruce L. Levine

DOI:

关键词:

摘要: The invention provides a method for inhibiting the depletion of healthy tissue during CAR T cell therapy comprising administering drug-molecule conjugate drug and molecule to subject receiving therapy, wherein binds expressed on surface cell. relates binding resulting in internalization into drug-mediated death

参考文章(11)
Xingluo Liu, Pan Zheng, Xuefeng Bai, Yang Liu, Methods of blocking tissue destruction by autoreactive T cells ,(2005)
Kenneth A. Foon, Sunil K. Chatterjee, Malaya Chatterjee, Monoclonal antibody 1A7 and related polypeptides ,(1996)
Bipulendu Jena, Sourindra Maiti, Helen Huls, Harjeet Singh, Dean A Lee, Richard E Champlin, Laurence JN Cooper, None, Chimeric Antigen Receptor (CAR)-Specific Monoclonal Antibody to Detect CD19-Specific T Cells in Clinical Trials PLoS ONE. ,vol. 8, pp. e57838- ,(2013) , 10.1371/JOURNAL.PONE.0057838
Peter D. Senter, Christine Bachy, Herren Wu, Michael S. Kinch, David Tice, Changshou Gao, Toxin conjugated eph receptor antibodies ,(2006)
Carl H. June, Michael D. Kalos, Michael C. Milone, David L. Porter, Bruce L. Levine, Use of chimeric antigen receptor-modified t cells to treat cancer ,(2011)
Charles G. Cerveny, Charlotte Mcdonagh, Dennis Benjamin, Paul Carter, Leigh Francisco, Hans Peter Gerber, Cd19 binding agents and uses thereof ,(2008)